Guardant Health
GH
#1787
Rank
A$16.14 B
Marketcap
A$123.10
Share price
-3.96%
Change (1 day)
71.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -A$0.64 Billion

According to Guardant Health 's latest financial reports the company's current earnings are A$0.98 Billion. , an increase over its 2024 earnings that were of -A$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.61 Billion-4.03%
2024 -A$0.64 Billion-9.12%
2023 -A$0.7 Billion-26.73%
2022 -A$0.96 Billion69.96%
2021 -A$0.56 Billion56.35%
2020 -A$0.36 Billion252.69%
2019 -A$0.11 Billion-17.22%
2018 -A$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-A$0.9 Billion 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-A$0.4 Billion-35.79%๐Ÿ‡บ๐Ÿ‡ธ USA